Login

The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River. 00:10:00

Share On Facebook Share On Twitter

Riber appoints Philippe Ley as CEO and board member

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Kovac Financial: Transforming Lives with Family-Oriented Support and Global Vision
00:10:00
Harmonizing Productivity: The Mori Keiichi of Focus System | Keiichi Mori , President of Focus Systems Corp
00:10:00
"Navigating Global Markets: Marc Rowan, CEO of Apollo Global Management, Shares Insights on the Future of Finance"
00:10:00
Long Run is the main focus to Investing firm |Brooks G. Gordon, Managing Director, W. P. Carey & Co. LLC
00:10:00
Labor Market Imbalances: A Challenge for the Federal Reserve
00:10:00
Apex Capital: Secure Investment Plans with Stable Returns and Diverse Options
00:10:00
Plausible Tomorrows: A Conversation with Vinod Khosla | Vinod Khosla, Founder,  Khosla Ventures.
00:10:00
"Decoding Private Equity Valuations: Insights from Mark Mansour of MCM Capital Partners | Mark Mansour - Managing Partner, MCM Capital Partners"
00:10:00
Copasa mobilizes and dispatches a team of specialists to Rio to address water-related issues.
00:00:00
Q&A with Carbios Chief Executive Officer Emmanuel Ladent | EMMANUEL LADENT, CHIEF EXECUTIVE OFFICER, CARBIOS
00:10:00
China Birth Rate Decline: Impact on Market and Strategies for Growth | Exclusive Interview |David Bortolussi,CEO,A2 Milk
00:10:00
The Benefits of Prime Venture Investments for Emerging Companies

© 2017 - Neuhu+